Blake Lively faces more legal trouble as her beauty brand strikes back with lawsuit - here's what the problem is
apparently is at the heart of multiple controversies lately. Blake Lively's beauty business is going through a lot of trouble.
Family Hive LLC
, her company, just filed a
trademark lawsuit
and is also dealing with the fallout from a well-known harassment case. Lively is having a rough time both personally and professionally. Her business is trying to protect its name, but sales are falling and she is still in legal trouble with co-star
Justin Baldoni
.
Why is Blake Lively's brand suing another company?
Blake Brown
, Blake Lively's growing hair care company, is in a trademark fight with a company based in Utah.
According to recent court filings, Utah-based businesswoman Kimberlie Hamner, the owner of the
Beauty by Blake
trademark, is being sued by Lively's company, Family Hive LLC.
The haircare brand Blake Lively is fighting to stop the competition's "Beauty By Blake" trademark. According to the lawsuit, consumers may become confused by Hamner's trademark because it is too similar to Blake Lively's brand name, as quoted in a report by the Blast.
Live Events
The Blake Brown product line was formally introduced at Target this summer, but the trademarks were all submitted in 2023 and are still pending approval. Notably, following Blake Lively's filings, Hamner submitted her Beauty by Blake trademark application in September 2024 with the intention of marketing "cosmetic oils" and "serums for cosmetic purposes."
What did the court documents reveal?
Leo M. Loughlin, the lawyer for Family Hive, stated in the document that was obtained by the Daily Mail that the competing trademark presents a likelihood of confusion and has the potential to damage the Blake Brown brand. He added that Hamner has "no connection whatsoever" to Family Hive and that his products could give consumers the false impression that the company is associated with or supports them.
ALSO READ:
As Musk exits, DOGE employees are being booted from offices; many fired staff now being rehired
How has the lawsuit with Justin Baldoni affected her business?
Following her sexual harassment lawsuit against Justin Baldoni in December 2024, Blake Lively's hair-care brand saw a sharp decline in sales, reportedly falling by as much as 78%. This latest lawsuit comes at a challenging time for her business endeavors.
The brand was once thought to be worth $100 million, but it is now predicted that Blake Brown will make less than $15 million in total sales in 2025. Lively's brand is still growing in the beauty industry, but the actress is currently balancing her business endeavors with courtroom drama. It's obvious that Blake Brown's future could be as complicated as a bad hair day, especially with trademark tensions escalating.
FAQs
What is Blake Lively's beauty brand suing for?
Her company claims that another brand's name, Beauty by Blake, is too similar and could confuse customers.
Is Blake's business struggling?
Yes, sales have decreased significantly, particularly since her lawsuit against actor Justin Baldoni made headlines.
Economic Times WhatsApp channel
)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Godrej Properties acquires 34 acres land in Vadodara
NEW DELHI: Mumbai-based Godrej Properties (GPL) has acquired 34 acres of land in Vadodara . The development on this land will primarily comprise of plotted residential units and will offer an estimated saleable area of nine lakh sq ft. This marks GPL's second land acquisition in Gujarat in the last one year. Earlier, in October 2024, the company had acquired a three-acre parcel in Vastrapur, Ahmedabad. The company recently acquired a 48-acre land parcel through outright purchase in Doddaballapur, Bengaluru. The development on this land will primarily comprise of plotted units with a development potential of 1.1 million sq ft.
Time of India
2 hours ago
- Time of India
Amid Trump tariff fears, Aurobindo strikes biggest deal; To acquire Lannett for Rs 2185 crore
Hyderabad: Amid rising fears of US President Donald Trump imposing tariffs on Indian pharma imports, Aurobindo Pharma is making its largest acquisition with a 100% stake in Lannett Company from US-based complex generics manufacturer Lannett Seller Holdco Inc for a total enterprise value of $250 million (approx. 2,185 crore) on a cash-free, debt-free basis. The acquisition, to be done through Aurobindo's wholly-owned US subsidiary Aurobindo Pharma USA Inc, will enable the company to expand its manufacturing footprint in the US, Aurobindo Pharma said in a regulatory filing. The Hyderabad-based company said the transaction aligns with its strategic objective to expand its US manufacturing footprint. Lannett has a 4.24 lakh sq ft cGMP (current good manufacturing practices) facility at Seymour in Indiana with a capacity to make around 3.6 billion tablets per annum. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad The plant has the capability to manufacture not just tablets but multiple dosage forms, including capsules, liquids, and powders. Aurobindo said Lannett's US-based facility has significant excess capacity and offers potential for further expansion. Lannett's plant has a strong regulatory and DEA (Drug Enforcement Administration) compliance track record and has built strong expertise in non-opioid controlled substances, mainly in ADHD (attention-deficit, hyperactivity disorder) therapeutics, as well as generic liquids. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Gold Is Surging in 2025 — Smart Traders Are Already In IC Markets Learn More Undo Apart from giving a manufacturing facility in the US, the deal will also give Aurobindo access to a complementary portfolio of profitable products as well as a growing contract development and manufacturing organisation business, it added. "The acquired product portfolio is primarily focused on non-opioid controlled substances, particularly in ADHD therapeutics in which Aurobindo currently has a limited presence. This acquisition strengthens Aurobindo's ability to serve the US generics space and provides strategic diversification into a specialised high-value therapeutic category," Aurobindo Pharma said. The transaction is expected to be completed in 8-12 months and is subject to US Federal Trade Commission approval in addition to other statutory and govt approvals. Though Aurobindo is acquiring Lannett Company Inc, the company will undergo a re-organisation to become Lannett Company LLC before Aurobindo acquires it. Lannett Company clocked a turnover of $306 million (approx. Rs 2674 crore) in the financial year 2024-25. The Lannett acquisition is Aurobindo Pharma's largest buy after its plan to acquire Sandoz's US dermatology and generic oral solids businesses for $1 billion in 2018 fizzled out because they could not secure approval from the US FTC in a timely manner.
Time of India
2 hours ago
- Time of India
T flags Rs 100 cr fake invoice fraud to Maha
Hyderabad: In a major move to curb tax fraud across state lines, the Telangana commercial taxes department has decided to formally notify the Maharashtra govt about the large-scale GST input credit scam involving fake invoices and empty vehicle shipments , a racket suspected to have siphoned off over ₹100 crore in taxes. At the heart of the scam is a Hyderabad-based company that issued high-value tax invoices for copper supplies to a company in Maharashtra, but with no actual movement of goods. According to preliminary findings, vehicles were dispatched empty from Telangana, while documentation falsely showed substantial consignments being transported. The fraudulent scheme revolves around the use of bogus input tax credit, one of the most common and damaging forms of GST fraud. These schemes typically involve shell or paper-only companies that issue invoices for goods or services that were never actually supplied, allowing colluding firms to illegitimately claim input tax credit from the govt. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad How the scam worked The operation followed a layered method of deception. A Hyderabad company generated fake invoices for copper goods, billing a Maharashtra firm without delivering any actual materials. The receiving company in Maharashtra then claimed to have paid 18% GST and sought input credit based on that fabricated transaction. The scam didn't end there. The Maharashtra firm recycled the fraud, issuing its own set of fake invoices to a third company, again falsely claiming to have supplied goods and paid tax. This chain of deceit allows each party to benefit from tax credits on taxes never actually paid, creating significant revenue losses for the govt. Vigilance intensified Commercial taxes commissioner K Haritha emphasised the expanding scope of the department's crackdown. "We are increasing vigilance regarding companies that create fake invoices or claim fraudulent input credits. Typically, this type of scam involves a chain of companies," she said. "We previously focused on identifying firms within our state, but now we will inform state govts about companies participating in this crime. If vigilance is heightened across all states, such fraudulent activities will decrease," she added. Big push against GST fraud Hyderabad: Since April 25, the commercial taxes department has stepped up enforcement and uncovered 304 fake GST cases. In these, ₹170 crore in fraudulent input tax credit was blocked, notices worth ₹49.7 crore were issued and ₹8.36 crore has already been recovered.
